Related Experiment Video
Updated: Feb 8, 2026

Biaxial Mechanical Characterizations of Atrioventricular Heart Valves
Published on: April 9, 2019
Coexistence of atrioventricular accessory pathways and drug-induced type 1 Brugada pattern
Can Hasdemir1, Jimmy Jyh-Ming Juang1, Sedat Kose2
1Department of Cardiology, Ege University School of Medicine, Izmir, Turkey.
Insights
Drug-induced type 1 Brugada electrocardiogram (ECG) pattern (DI-Type1-BrP) is common in patients with atrioventricular accessory pathways (AV-APs). Specific ECG findings during preexcitation and tachycardia can indicate underlying DI-Type1-BrP and risk for arrhythmias.
Area of Science:
- Cardiology
- Electrophysiology
- Genetics
Background:
- Atrial arrhythmias, including atrioventricular nodal reentrant tachycardia, can co-occur with drug-induced type 1 Brugada electrocardiogram (ECG) pattern (DI-Type1-BrP).
- Patients with atrioventricular accessory pathways (AV-APs) may present with coexisting DI-Type1-BrP.
Purpose of the Study:
- To determine the prevalence of DI-Type1-BrP in patients with AV-APs.
- To investigate the clinical, electrocardiographic, electrophysiologic, and genetic characteristics of patients with AV-APs and DI-Type1-BrP.
Main Methods:
- 124 patients with AV-APs and 84 controls underwent an ajmaline challenge test to detect DI-Type1-BrP.
- Genetic screening was performed in 55 patients (19 with and 36 without DI-Type1-BrP).
Main Results:
- DI-Type1-BrP was unmasked more frequently in patients with AV-APs (16.1%) compared to controls (4.8%).
- Patients with DI-Type1-BrP exhibited distinct ECG patterns during preexcitation and orthodromic atrioventricular reentrant tachycardia (AVRT), including QRS abnormalities in V2.
- A higher prevalence of mutations in Brugada-susceptibility genes was observed in patients with DI-Type1-BrP (36.8%) versus those without (8.3%).
Conclusions:
- DI-Type1-BrP is prevalent in patients with AV-APs.
- Specific 12-lead ECG characteristics during preexcitation and AVRT can identify patients with underlying DI-Type1-BrP.
- These findings suggest an increased risk for malignant arrhythmias in patients with AV-APs and DI-Type1-BrP.
Background:
Atrial arrhythmias, particularly atrioventricular nodal reentrant tachycardia, can coexist with drug-induced type 1 Brugada electrocardiogram (ECG) pattern (DI-Type1-BrP). The present study was designed to determine the prevalence of DI-Type1-BrP in patients with atrioventricular accessory pathways (AV-APs) and to investigate the clinical, electrocardiographic, electrophysiologic, and genetic characteristics of these patients.
Methods:
One-hundred twenty-four consecutive cases of AV-APs and 84 controls underwent an ajmaline challenge test to unmask DI-Type1-BrP. Genetic screening and analysis was performed in 55 of the cases (19 with and 36 without DI-Type1-BrP).
Results:
Patients with AV-APs were significantly more likely than controls to have a Type1-BrP unmasked (16.1 vs 4.8%, P = 0.012). At baseline, patients with DI-Type1-BrP had higher prevalence of chest pain, QR/rSr' pattern in V1 and QRS notching/slurring in V2 and aVL during preexcitation, rSr' pattern in V1 -V2 , and QRS notching/slurring in aVL during orthodromic atrioventricular reentrant tachycardia (AVRT) compared to patients without DI-Type1-BrP. Abnormal QRS configuration (QRS notching/slurring and/or fragmentation) in V2 during preexcitation was present in all patients with DI-Type1 BrP. The prevalence of spontaneous preexcited atrial fibrillation (AF) and history of AF were similar (15% vs 18.3%, P = 0.726) in patients with and without DI-Type1-BrP, respectively. The prevalence of mutations in Brugada-susceptibility genes was higher (36.8% vs 8.3%, P = 0.02) in patients with DI-Type1-BrP compared to patients without DI-Type1-BrP.
Conclusions:
DI-Type1-BrP is relatively common in patients with AV-APs. We identify 12-lead ECG characteristics during preexcitation and orthodromic AVRT that point to an underlying type1-BrP, portending an increased probability for development of malignant arrhythmias.
Related Concept Videos
Accessory Organs
Accessory Structures of the Skin: Hair Growth and Types
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antihypertensive Drugs: Action of β1 Blockers
Antihypertensive Drugs: Types of β-Blockers
RNA Polymerase II Accessory Proteins

